trending Market Intelligence /marketintelligence/en/news-insights/trending/tzjytzlljhooi4cvez7ybg2 content esgSubNav
In This List

DiaMedica Therapeutics appoints chief medical officer

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


DiaMedica Therapeutics appoints chief medical officer

Minneapolis-based biotechnology company DiaMedica Therapeutics Inc. appointed Harry Alcorn Jr. as chief medical officer.

Alcorn previously served as chief scientific officer at DaVita Clinical Research. He has also served on the boards of the Association of Clinical Pharmacology Units and MEDTOX Laboratories Inc.

DiaMedica develops treatments for neurological and kidney diseases.